Revealing Cancer's Secrets: Tracking Tumors In Vivo Using Reporter-Labeled Cell Lines
November 13, 2025, at 12:00 PM ETIn preclinical research, in vivo imaging using mouse models is an indispensable tool in visualizing the development of tumor, the progression, and its response to therapies. Reporter-labeled cell lines offer a straightforward, high-throughput, and robust means to quantitatively assess tumor burden longitudinally and non-invasively. This webinar highlights recent advances for in vivo applications of ATCC-generated reporter-labeled cell lines.
Key takeaways:
- Diversity in tumor xenograft models
- Use of syngeneic models in immunotherapy studies
- Reporter-labeled isogenic cell lines for drug resistance studies
Hyeyoun Chang, PhD
Scientist, ATCC
Hyeyoun Chang, PhD, is a Scientist in the Immuno-oncology group of the R&D department at ATCC. She has extensive experience in the fields of biomedical engineering and cancer biology that focuses on drug delivery, intracellular signaling, and gene therapy. Prior to joining ATCC, Dr. Chang received her PhD in biomedical engineering from Korea University of Science and Technology and completed her postdoctoral training at Dana-Farber Cancer Institute/ Harvard Medical School.
John Foulke, MS
Lead Biologist, ATCC
John Foulke is a Lead Biologist in the Immuno-Oncology group in the R&D department at ATCC. John joined the ATCC cell biology R&D group in 2008, and he has led many projects centered on the development of novel cell lines and cell-based reporter systems to support cancer research community. His work is mainly focused on developing innovative cell models for research and drug discovery in the immuno-oncology field.
